Search Browse Earnings

BIOTRICITY INC.

OTC:BTCY

Surgical & Medical Instruments & Apparatus·REDWOOD CITY, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

BIOTRICITY INC. — SlamSEC

Revenue

$12.1M

+25.2% YoY

FY 2025

Adj. EBITDA

-$8.8M

-73.2% margin

FY 2025

Net Income

-$14.1M

-116.8% margin

FY 2025

EPS (Diluted)

-$1.66

FY 2025

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$786,060

FY 2025

Total Debt

—

Net Cash

$786,060

FY 2025

Enterprise Value

—

Debt / EBITDA

0.1x

FY 2025

EV / EBITDA

—

Employees

—

CEO

Al-Siddiq Waqaas

CFO

Ayanoglou John